oncorus.comHealthcareFounded: 2015Funding to Date: $140.5MM
Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of immune system to treat solid tumors.
